Castle Biosciences Inc.
CSTL | NASDAQ
$34.99
-$0.35 (-0.99%)
At close: Sep 21, 2026, 4:00 PM ET
$34.99
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 357.28M | 339.92M | 344.23M | 343.53M | 346.27M | 347.08M | 332.07M | 311.88M | 287.59M | 250.73M | 219.79M | 192.01M | 167.52M | 152.22M | 137.04M | 123.74M | 110.2M | 98.12M | 94.09M | 86.35M | 78.09M | 68.04M |
Cost of Revenue | 60.32M | 77.95M | 71.03M | 68.9M | 65.8M | 62.69M | 60.21M | 56.45M | 52.16M | 48.69M | 44.98M | 42.08M | 39.62M | 36.25M | 32.01M | 27.09M | 22.73M | 18.74M | 15.82M | 13.9M | 11.87M | 10.32M |
Gross Profit | 193.41M | 261.97M | 273.2M | 274.63M | 280.47M | 284.39M | 271.86M | 255.43M | 235.43M | 202.03M | 174.81M | 149.93M | 127.91M | 115.98M | 105.03M | 96.65M | 87.48M | 79.39M | 78.26M | 72.45M | 66.21M | 57.72M |
Operating Income | -29.04M | -33.29M | -42.81M | -34.93M | -23.05M | -13.79M | 8.67M | -1.04M | -15.76M | -41.93M | -67.98M | -85.15M | -97.05M | -100.26M | -93.25M | -85.59M | -75.87M | -60.31M | -40.08M | -27.94M | -20.03M | -11.86M |
Interest Income | 10.63M | 11.22M | 11.77M | 12.25M | 12.82M | 13.02M | 12.92M | 12.66M | 12.03M | 11.28M | 10.62M | 9.78M | 8.3M | 6.27M | 3.97M | 1.71M | 440K | 94K | 68K | 70K | 65K | 79K |
Pretax Income | -19.2M | -17.66M | -29.51M | -18.92M | -10.25M | -2.22M | 21.56M | 11.14M | -4.02M | -30.66M | -57.37M | -75.39M | -88.76M | -73.61M | -68.9M | -63.5M | -55.04M | -60.22M | -40.01M | -29.66M | -22.46M | -15.05M |
Net Income | -19.42M | -12.83M | -24.16M | -12.24M | -9.47M | -5.07M | 18.25M | 6.08M | -3.1M | -30.8M | -57.47M | -75.5M | -88.85M | -71.72M | -67.14M | -52.95M | -44.49M | -51.64M | -31.29M | -29.75M | -22.55M | -15.13M |
Selling & General & Admin | 243.66M | 235.6M | 229.32M | 222.56M | 217.15M | 210.17M | 200.05M | 194.17M | 188.29M | 181.89M | 180.15M | 174.49M | 166.5M | 159.31M | 143M | 129.74M | 115.71M | 99.03M | 86.74M | 76.54M | 65.65M | 55.22M |
Research & Development | 55.45M | 53.69M | 51.85M | 50.01M | 49.38M | 50.72M | 51.95M | 53.26M | 53.86M | 53.03M | 53.62M | 51.93M | 49.92M | 48.54M | 44.9M | 43.04M | 39.63M | 34.5M | 29.65M | 24.78M | 20.34M | 16.25M |
Other Expenses | 29.96M | 5.97M | 34.84M | 37M | 36.99M | 37.28M | 11.2M | 9.04M | 9.04M | 9.04M | 9.01M | 8.66M | 8.54M | 8.39M | 10.38M | 9.47M | 8.01M | 6.17M | 1.96M | -932K | 256K | -1.88M |
Operating Expenses | 329.06M | 295.26M | 316.01M | 309.57M | 303.52M | 298.18M | 263.19M | 256.47M | 251.19M | 243.96M | 242.78M | 235.08M | 224.95M | 216.24M | 198.28M | 182.25M | 163.35M | 139.7M | 118.34M | 100.39M | 86.24M | 69.58M |
Interest Expense | -11K | 203K | 86K | 154K | 331K | 580K | 577K | 487K | 288K | 21K | 11K | 13K | 17K | 18K | 17K | 14K | 8K | 4K | 1K | 395K | 1.1M | 1.87M |
Selling & Marketing Expenses | 66.18M | 101.31M | 138.12M | 135.13M | 132.18M | 129.73M | 123.47M | 120.02M | 118.68M | 114.26M | 113.66M | 86.69M | 80.59M | 73.91M | 62.19M | 62.19M | 53.04M | 43.33M | 25.11M | 25.11M | 11.87M | n/a |
Cost & Expenses | 282.77M | 373.21M | 387.04M | 378.46M | 369.32M | 360.87M | 323.4M | 312.92M | 303.35M | 292.65M | 287.77M | 277.16M | 264.57M | 252.48M | 230.29M | 209.33M | 186.07M | 158.44M | 134.16M | 114.29M | 98.11M | 79.91M |
Income Tax Expense | 212K | -4.82M | -5.36M | -6.68M | -781K | 2.85M | 3.32M | 5.06M | -918K | 132K | 101K | 119K | 87K | -1.89M | -1.77M | -10.55M | -10.55M | -8.59M | -8.72M | 89K | 89K | 84K |
Shares Outstanding (Basic) | 30.4M | 29.89M | 29.33M | 25.05M | 28.91M | 28.61M | 28.13M | 27.84M | 27.65M | 27.49M | 27.14M | 26.83M | 26.73M | 26.61M | 26.4M | 26.32M | 26.06M | 25.42M | 25.33M | 25.29M | 25.09M | 24.91M |
Shares Outstanding (Diluted) | 30.4M | 29.89M | 29.33M | 29.07M | 29.55M | 28.61M | 30.2M | 29.4M | 28.74M | 27.49M | 27.14M | 26.83M | 26.73M | 26.61M | 26.4M | 26.32M | 26.06M | 25.42M | 25.33M | 25.29M | 25.09M | 24.91M |
EPS (Basic) | -0.66 | -0.43 | -0.84 | -0.42 | -0.32 | -0.16 | 0.65 | 0.22 | -0.13 | -1.15 | -2.16 | -2.84 | -3.35 | -2.71 | -2.58 | -2.05 | -1.75 | -2.04 | -1.24 | -1.22 | -0.98 | -0.71 |
EPS (Diluted) | -0.66 | -0.44 | -0.85 | -0.45 | -0.35 | -0.19 | 0.62 | 0.20 | -0.14 | -1.15 | -2.16 | -2.84 | -3.35 | -2.71 | -2.58 | -2.05 | -1.75 | -2.04 | -1.24 | -1.22 | -0.98 | -0.71 |
EBITDA | -4.02M | -725.67K | 13.13M | 25.79M | 32.57M | 40.78M | 38.14M | 25.08M | 9.36M | -17.87M | -45.02M | -63.43M | -77.05M | -62.3M | -58.34M | -54.33M | -47.71M | -54.89M | -36.6M | -27.15M | -20.21M | -12.57M |
EBIT | -17.36M | -17.48M | -29.45M | -18.79M | -9.92M | -1.64M | 22.14M | 11.63M | -3.73M | -30.64M | -57.35M | -75.37M | -88.74M | -73.59M | -68.89M | -63.48M | -55.03M | -60.22M | -40.01M | -29.27M | -21.36M | -13.18M |
Depreciation & Amortization | 13.34M | 16.75M | 42.59M | 44.58M | 42.49M | 42.42M | 16M | 13.45M | 13.09M | 12.78M | 12.33M | 11.95M | 11.7M | 11.28M | 10.54M | 9.15M | 7.32M | 5.33M | 3.41M | 2.12M | 1.15M | 614K |
Add to Watchlist
Select watchlists to add or remove CSTL